FIELD: medicine.
SUBSTANCE: claimed invention relates to transdermal plaster, suitable for introduction of nitroglycerine, which includes lining layer, matrix layer, nitroglycerine, transversally linked copolymer acrylic acid/2-ethyl-acrylate/methyl-acrylate, sorbitan monooleate, propylene glycol and pharmacologically acceptable filling agents.
EFFECT: plaster ensures permeability of sufficient nitroglycerine amount without necessity to use adsorption absorbers.
15 cl, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| TRANSDERMAL DEVICE, INCLUDING POROUS MICROPARTICLES | 2013 |
|
RU2627869C2 |
| TRANSDERMALLY ABSORBABLE FORMULATION CONTAINING DONEPEZIL | 2010 |
|
RU2545696C2 |
| TRANSDERMAL COMPOSITION CONTAINING DONEPEZIL AS ACTIVE INGREDIENT | 2015 |
|
RU2713207C2 |
| TRANSDERMAL DONEPEZIL DELIVERY SYSTEM | 2017 |
|
RU2779471C2 |
| TRANSDERMAL MEMANTINE DELIVERY SYSTEMS | 2017 |
|
RU2764764C2 |
| PREPARATIVE FORMS OF MEDICATIONS AGAINST DEMENTIA FOR TRANSCUTANEOUS INTRODUCTION | 2006 |
|
RU2428179C2 |
| TRANSDERMAL THERAPEUTIC SYSTEM | 2020 |
|
RU2791107C1 |
| DEVICE FOR TRANSDERMAL BISOPROLOL INTRODUCTION | 2008 |
|
RU2440811C2 |
| TRANSDERMAL THERAPEUTIC SYSTEM FOR TRANSDERMAL INJECTION OF GUANFACINE, CONTAINING SILICONE POLYMER | 2018 |
|
RU2792822C2 |
| TRANSDERMAL THERAPEUTIC SYSTEM FOR TRANSDERMAL ADMINISTRATION OF GUANFACINE CONTAINING AT LEAST ONE EXCIPIENT | 2018 |
|
RU2812734C2 |
